Hepacure Pharma
Partnered: 2024
Geography: Israel
Vertical: Life Sciences
www.hepacure-pharma.com Novel peptide therapy for fatty liver disease (NAFLD), addressing fat build-up linked to diabetes, hypertension, and kidney disease. Aims to improve liver function and prevent disease progression.
Backed by NGT Healthcare II.